-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
joel young
-
Preprint Solriamfetol improves daily fatigue symptoms in adults with [ME/CFS] after eight weeks of treatment, 2025, Young et al
Abstract: Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term illness with no treatment options that address the disease directly. Solriamfetol is a selective dual norepinephrine-dopamine reuptake inhibitor that promotes wakefulness in obstructive sleep apnea...- Nightsong
- Thread
- joel young solriamfetol
- Replies: 18
- Forum: ME/CFS research
-
Open A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Joel L Young, 2020
https://www.clinicaltrials.gov/ct2/show/NCT04622293 https://thejewishnews.com/2020/10/07/new-hope-for-chronic-fatigue-sufferers/- John Mac
- Thread
- adhd dopamine joel young norepinephrine solriamfetol sunosi treatment
- Replies: 9
- Forum: Recruitment into current ME/CFS research studies
-
Psychology Today: What We Need to Know About Chronic Fatigue - Joel L. Young M.D.
Annoying sales pitch of this psychiatrist's book "Understanding and Treating Chronic Fatigue: A Practical Guide for Patients, Families, and Practitioners (Praeger, 2020). He's also conducted a small trial ten years ago on CFS and the ADHD drug lisdexamfetamine (LDX). Perhaps the central tension...- Kalliope
- Thread
- book chronic fatigue joel young
- Replies: 11
- Forum: Psychosomatic news - ME/CFS and Long Covid